Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial.
Study Goal
The researchers aimed to determine whether a 12-week laughter yoga program could improve glycemic control in individuals with type 2 diabetes.
Results Summary
The laughter yoga group showed significant improvements in HbA1c levels and positive affect scores, with a trend toward increased sleep duration. The program had a high attendance rate (92.9%), indicating feasibility.
Population
42 participants with type 2 diabetes.
Effective Dosage
12-week laughter yoga program (frequency not specified).
Duration
12 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
a 12-week laughter yoga program | decrease | HbA1c levels | individuals with type 2 diabetes | -0.31% (between-group difference) | significant improvements | #1 |
a 12-week laughter yoga program | increase | positive affect scores | individuals with type 2 diabetes | 0.62 points (between-group difference) | significant improvements | #2 |
a 12-week laughter yoga program | increase | sleep duration | individuals with type 2 diabetes | 0.4 hours (between-group difference) | tended to increase | #3 |
a 12-week laughter yoga program | neutral | - | individuals with type 2 diabetes | - | is feasible | #4 |
BACKGROUND: Laughter has been reported to have various health benefits. However, data on the long-term effects of laughter interventions on diabetes are limited. This study aimed to investigate whether laughter yoga can improve glycemic control among individuals with type 2 diabetes. METHODS: In a single-center, randomized controlled trial, 42 participants with type 2 diabetes were randomly assigned to either the intervention or the control group. The intervention consisted of a 12-week laughter yoga program. Hemoglobin A1c (HbA1c), body weight, waist circumference, psychological factors, and sleep duration were evaluated at baseline and week 12. RESULTS: Intention-to-treat analysis showed that participants in the laughter yoga group experienced significant improvements in HbA1c levels (between-group difference: -0.31%; 95% CI -0.54, -0.09) and positive affect scores (between-group difference: 0.62 points; 95% CI 0.003, 1.23). Sleep duration tended to increase in the laughter yoga group with a between-group difference of 0.4 hours (95% CI -0.05, 0.86; P = 0.080). The mean attendance rate for laughter yoga program was high (92.9%). CONCLUSIONS: A 12-week laughter yoga program is feasible for individuals with type 2 diabetes and improves glycemic control. These findings suggest that having fun could be a self-care intervention. Further studies with larger numbers of participants are warranted to better evaluate the effects of laughter yoga. CLINICAL TRIAL REGISTRATION: http://www.chinadrugtrials.org.cn, identifier UMIN000047164.